Literature DB >> 32654689

Defining Common Variable Immunodeficiency Disorders in 2020.

Rohan Ameratunga1, Caroline Allan2, See-Tarn Woon3.   

Abstract

Common variable immunodeficiency disorders (CVID) are the most frequent symptomatic primary immune deficiency in adults. Because there is no known cause for these conditions, there is no single clinical feature or laboratory test that can confirm the diagnosis with certainty. If a causative mutation is identified, patients are deemed to have a CVID-like disorder caused by a specific primary immunodeficiency/inborn error of immunity. In the remaining patients, the explanation for these disorders remains unclear. The understanding of CVID continues to evolve and the authors review recent studies, which have addressed some of these uncertainties.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CVID; Common variable immunodeficiency; Diagnostic criteria; HGUS; Hypogammaglobulinemia; IVIG; SCIG; THA

Mesh:

Year:  2020        PMID: 32654689     DOI: 10.1016/j.iac.2020.03.001

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  9 in total

1.  SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?

Authors:  Rohan Ameratunga; Euphemia Leung; See-Tarn Woon; Lydia Chan; Richard Steele; Klaus Lehnert; Hilary Longhurst
Journal:  J Allergy Clin Immunol Pract       Date:  2022-06-22

Review 2.  Perspective: Application of the American College of Medical Genetics Variant Interpretation Criteria to Common Variable Immunodeficiency Disorders.

Authors:  Rohan Ameratunga; Caroline Allan; Klaus Lehnert; See-Tarn Woon
Journal:  Clin Rev Allergy Immunol       Date:  2021-04-05       Impact factor: 8.667

3.  Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study.

Authors:  R Ameratunga; A Jordan; A Cavadino; S Ameratunga; T Hills; R Steele; M Hurst; B McGettigan; I Chua; M Brewerton; N Kennedy; W Koopmans; Y Ahn; R Barker; C Allan; P Storey; C Slade; A Baker; L Huang; S-T Woon
Journal:  Clin Exp Immunol       Date:  2021-04-12       Impact factor: 5.732

4.  What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review.

Authors:  Astrid C van Stigt; Willem A Dik; Lieke S J Kamphuis; Bas M Smits; Joris M van Montfrans; P Martin van Hagen; Virgil A S H Dalm; Hanna IJspeert
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

5.  Perspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection.

Authors:  Rohan Ameratunga; See-Tarn Woon; Richard Steele; Russell Snell; Natalie Medlicott; Emily Mears; Euphemia Leung; Klaus Lehnert; Anthony Jordan; Shyamal Das; William Abbott; Hilary Longhurst; Miguel E Quiñones-Mateu
Journal:  Expert Rev Clin Immunol       Date:  2021-05-14       Impact factor: 4.473

6.  Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)-A Case Report.

Authors:  Blair Merrick; Aravind Gokul Tamilarasan; Raphael Luber; Patrick F K Yong; Kuldeep Cheent; Peter M Irving; Manjula Meda; Simon D Goldenberg
Journal:  Infect Dis Rep       Date:  2022-01-12

7.  Common Variable Immunodeficiency-Associated Cancers: The Role of Clinical Phenotypes, Immunological and Genetic Factors.

Authors:  Luzia Bruns; Victoria Panagiota; Sandra von Hardenberg; Gunnar Schmidt; Ignatius Ryan Adriawan; Eleni Sogka; Stefanie Hirsch; Gerrit Ahrenstorf; Torsten Witte; Reinhold Ernst Schmidt; Faranaz Atschekzei; Georgios Sogkas
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

8.  Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients.

Authors:  Rohan Ameratunga; See-Tarn Woon; Richard Steele; Klaus Lehnert; Euphemia Leung; Emily S J Edwards; Anna E S Brooks
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

9.  Are All Primary Immunodeficiency Disorders Inborn Errors of Immunity?

Authors:  Rohan Ameratunga; Hilary Longhurst; Klaus Lehnert; Richard Steele; Emily S J Edwards; See-Tarn Woon
Journal:  Front Immunol       Date:  2021-07-21       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.